Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Arizona State University | OTHER |
Not provided
Not provided
Not provided
Not provided
This study will examine the feasibility and acceptability of an innovative game-based intervention designed for families of youth aged 11-14 to promote HPV vaccination; will explore changes in key outcomes and related measures; and will identify factors contributing to or impeding effective implementation in health clinic settings. The intervention and its approach have the potential to reduce health disparities in HPV-associated cancers in youth via low-cost technology and timely intervention.
Guided by Social Cognitive Theory, we propose to
Parent-youth dyads in the intervention will play HPV Detective (tablet format) at the clinic prior to the healthcare provider visits. The control dyads will receive standard clinic treatment.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| HPV game group | Experimental | Parent-child dyads receive a HPV game intervention |
|
| Usual care | No Intervention | Parent-child dyads receive child's usual care |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| HPV game | Behavioral | A brief health game for parent-child dyads to promote child's HPV vaccination |
|
| Measure | Description | Time Frame |
|---|---|---|
| Percentage of eligible individuals agreeing to participate | Assessed by the % of eligible individuals agreeing to participate | 2 years |
| Percentage of eligible individuals who complete the intervention (intervention arm only) and assessments (all participants) | Assessed by the % of eligible individuals who complete the intervention and assessments | 2 years |
| Ease of use (intervention arm only) | (1) device-recorded time to complete interactive modules and the full game; (2) self reported easy of use | 2 years |
| Parent and child acceptability of the intervention (intervention arm only) | Assessed by a 12-item Likert scale. | 2 years |
| Intention to vaccinate the child against HPV | Assessed by a Likert scale question: how likely will you (parent) vaccinate your child against HPV? Responses: (1) Very unlikely to (5) Very likely | 2 years |
| Child vaccination status (1st & 2nd doses). | Assessed by one binary (yes/no) question regarding whether or not the child has received the 1st & 2nd dose of HPV vaccine. | 2 years |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| ANGELA CHEN, PhD | Michigan State University | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Michigan State University | East Lansing | Michigan | 48824 | United States |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 41746039 | Result | Reifsnider E, Subedi S, Ghonaim N, Whaley M, Chen AC. Acceptability, Usability, and Clinical Integration of a Clinic-Based Digital Game for HPV Education: Qualitative Perspectives from Adolescents, Parents, and Healthcare Providers. Vaccines (Basel). 2026 Jan 26;14(2):116. doi: 10.3390/vaccines14020116. |
Not provided
Not provided
This study will provide de-identified survey data stored in an encrypted electronic database. They will be available free of identifiers to avoid the possibility of disclosing identify of research participants. Quantitative data collected from this study will be made available to qualified scientists for research purposes following acceptance for publication of the main findings derived from the final data set.
The data will be available when the award ends and following acceptance for publication of the main findings derived from the final data set. It will be available for 10 years.
The data will remain the property of the provider; the recipient shall show proof of appropriate training in the responsible conduct of research; any publication resulting from use of the data will acknowledge the provider and NIH of the original project from which the data were derived; the data will not be used for commercial or for-profit purposes; the data will not be further distributed to others; the provider makes no representations and extends no warranties of any kind, either expressed or implied; the recipient shall assume all liability for claims for damages against it by third parties that may arise from the use of the data; the recipient agrees to pay the cost of preparation and distribution of the data. Availability and use of the data may be limited by additional local institutional review board policies or by local, state, and federal laws and regulations.
Not provided
Not provided
| ID | Term |
|---|---|
| D030361 | Papillomavirus Infections |
| D000079263 | Vaccine-Preventable Diseases |
| ID | Term |
|---|---|
| D015229 | Sexually Transmitted Diseases, Viral |
| D012749 | Sexually Transmitted Diseases |
| D003141 | Communicable Diseases |
| D007239 | Infections |
Not provided
Not provided
intervention vs. usual care (control)
Not provided
Not provided
Not provided
| D004266 | DNA Virus Infections |
| D014777 | Virus Diseases |
| D014412 | Tumor Virus Infections |
| D000091662 | Genital Diseases |
| D000091642 | Urogenital Diseases |
| D020969 | Disease Attributes |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |